Literature DB >> 23774033

Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro.

Joanne M O'Hara1, Nicholas J Mantis.   

Abstract

The penultimate event in the intoxication of mammalian cells by ricin toxin is the reduction, in the endoplasmic reticulum (ER), of the intermolecular disulfide bond that links ricin's enzymatic (RTA) and binding (RTB) subunits. In this report we adapted an in vitro protein disulfide isomerase (PDI)-mediated reduction assay to test the hypothesis that the RTA-specific neutralizing monoclonal antibody (mAb) IB2 interferes with the liberation of RTA from RTB. IB2 recognizes an epitope located near the interface between RTA and RTB and, like a number of other RTA-specific neutralizing mAbs, is proposed to neutralize ricin intracellularly. In this study, we found that IB2 virtually eliminated the reduction of ricin holotoxin into RTA and RTB in vitro. Surprisingly, three other neutralizing mAbs (GD12, R70 and SyH7) that bind epitopes at considerable distance from ricin's disulfide bond were as effective (or nearly as effective) as IB2 in interfering with PDI-mediated liberation of RTA from RTB. By contrast, two non-neutralizing RTA-specific mAbs, FGA12 and SB1, did not affect PDI-mediated reduction of ricin. These data reveal a possible mechanism by which RTA-specific antibodies may neutralize ricin intracellularly, provided they are capable of trafficking in association with ricin from the cell surface to the ER.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Intracellular; Neutralization; Toxin

Mesh:

Substances:

Year:  2013        PMID: 23774033      PMCID: PMC3753220          DOI: 10.1016/j.jim.2013.06.004

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  36 in total

1.  Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin.

Authors:  B Tsai; C Rodighiero; W I Lencer; T A Rapoport
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

Review 2.  Pathways followed by ricin and Shiga toxin into cells.

Authors:  Kirsten Sandvig; Stine Grimmer; Silje Ugland Lauvrak; Maria Lyngaas Torgersen; Grethe Skretting; Bo van Deurs; Tore Geir Iversen
Journal:  Histochem Cell Biol       Date:  2001-11-20       Impact factor: 4.304

Review 3.  Structural and mechanistic insight into how antibodies inhibit serine proteases.

Authors:  Rajkumar Ganesan; Charles Eigenbrot; Daniel Kirchhofer
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

4.  Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin A-chain vaccine-RVEc™.

Authors:  Michael M Meagher; Javier G Seravalli; S Todd Swanson; Roger G Ladd; Yogender P Khasa; Mehmet Inan; Jay C Harner; Scott K Johnson; Kevin Van Cott; Changhong Lindsey; Robert Wannemacher; Leonard A Smith
Journal:  Biotechnol Prog       Date:  2011-05-31

5.  A systematic comparison of free and bound antibodies reveals binding-related conformational changes.

Authors:  Inbal Sela-Culang; Shahar Alon; Yanay Ofran
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

6.  Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.

Authors:  Ellen S Vitetta; Joan E Smallshaw; John Schindler
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

7.  Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.

Authors:  Joanne M O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

8.  Hot spots for allosteric regulation on protein surfaces.

Authors:  Kimberly A Reynolds; Richard N McLaughlin; Rama Ranganathan
Journal:  Cell       Date:  2011-12-23       Impact factor: 41.582

9.  Structure and evolution of ricin B chain.

Authors:  E Rutenber; M Ready; J D Robertus
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

10.  Reductive activation of type 2 ribosome-inactivating proteins is promoted by transmembrane thioredoxin-related protein.

Authors:  Matteo Pasetto; Erika Barison; Monica Castagna; Pietro Della Cristina; Cristina Anselmi; Marco Colombatti
Journal:  J Biol Chem       Date:  2012-01-06       Impact factor: 5.486

View more
  19 in total

1.  A monoclonal antibody to an abrin chimera recognizing a unique epitope on abrin A chain confers protection from abrin-induced lethality.

Authors:  Meenakshi Sundaram Kumar; Anjali A Karande
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

2.  Recent advances in the development of vaccines against ricin.

Authors:  Robert N Brey; Nicholas J Mantis; Seth H Pincus; Ellen S Vitetta; Leonard A Smith; Chad J Roy
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

3.  Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies.

Authors:  Andrea Bazzoli; David J Vance; Michael J Rudolph; Yinghui Rong; Siva Krishna Angalakurthi; Ronald T Toth; C Russell Middaugh; David B Volkin; David D Weis; John Karanicolas; Nicholas J Mantis
Journal:  Proteins       Date:  2017-08-04

4.  Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.

Authors:  David J Vance; Jacqueline M Tremblay; Nicholas J Mantis; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

5.  Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.

Authors:  Kaushik Dutta; Avanish K Varshney; Matthew C Franklin; Michael Goger; Xiaobo Wang; Bettina C Fries
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

6.  Crystal structures of ricin toxin's enzymatic subunit (RTA) in complex with neutralizing and non-neutralizing single-chain antibodies.

Authors:  Michael J Rudolph; David J Vance; Jonah Cheung; Matthew C Franklin; Fiana Burshteyn; Michael S Cassidy; Ebony N Gary; Cristina Herrera; Charles B Shoemaker; Nicholas J Mantis
Journal:  J Mol Biol       Date:  2014-06-04       Impact factor: 5.469

7.  High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin.

Authors:  David J Vance; Jacqueline M Tremblay; Yinghui Rong; Siva Krishna Angalakurthi; David B Volkin; C Russell Middaugh; David D Weis; Charles B Shoemaker; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

8.  High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine.

Authors:  Ronald T Toth; Siva Krishna Angalakurthi; Greta Van Slyke; David J Vance; John M Hickey; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; David D Weis; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

Review 9.  Progress and challenges associated with the development of ricin toxin subunit vaccines.

Authors:  David J Vance; Nicholas J Mantis
Journal:  Expert Rev Vaccines       Date:  2016-04-06       Impact factor: 5.217

10.  Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA).

Authors:  Joanne M O'Hara; Jane C Kasten-Jolly; Claire E Reynolds; Nicholas J Mantis
Journal:  Immunol Lett       Date:  2013-11-21       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.